As increased marijuana legalization permits expansion into recreational and medical spaces, the two segments are anticipated to separate as companies within either, or both, of the two industries implement different strategies to target their consumers. Analyst firm Jefferies’ current models of the global medical market stand at $8 billion for this year and then rising to $19 billion by 2029. The firm also forecasts the recreational market at $9 billion for 2019 and then amounting to $31 billion by 2029.
“Medical and [recreational] are broadly similar now but will become two distinct segments. Rec. will be about creating brands and delivering differentiating experiences, while medical will be about developing unique and specific drug formulations, with exacting pharma ingredients, protected by IP” according to Jefferies’ analyst Owen Bennett.
Jefferies is the latest of the Wall Street firms to add marijuana to their coverage, following the likes of Cowen and Piper Jaffray whom already cover the budding industry. With that being said, it may be wise for investors to also keep tabs on the nascent industry and marijuana stocks.
Leafbuyer Technologies, Inc. (LBUY) announced the official launch of the leading mobile app Greenlight in Colorado and Oklahoma, further to the company’s announcement of the acquisition of Greenlight back in November. Previously, the loyalty and order ahead app was only available in California and now 25 Leafbuyer dispensary clients throughout Colorado and Oklahoma have signed up to give consumers access to preorder cannabis products and skip the line to pick up products. This news followed the announcement that Leafbuyer and Greenlight now integrate with Flowhub’s point of sale and compliance technology, giving customers have access to immediate, up-to-date menu information regarding product availability in dispensaries using Flowhub API and Leafbuyer platforms.
“In this fast-paced industry, we need to stay ahead of technology and continuously improve our offerings to drive more value to our clients,” said Kurt Rossner, CEO. “Greenlight is one more platform we have that separates us from our competition, inherently making Leafbuyer a more attractive option to dispensary clients nationwide.”
Further the Leafbuyer’s mid-February news release, the company reported signing up more than 50 licensed medical dispensaries within the Oklahoma market. Kurt Rossner commented, “Our success within the Oklahoma market is a direct result of aggressive marketing and sales initiatives. We plan to replicate the strategies we used in Oklahoma within other emerging markets, boosting revenue and expanding our national footprint”.
Isodiol International Inc. (ISOLF) (ISOL.CN) announced the launch of its products with Holland & Barrett International, a leading European health and wellness retailer, beginning with an initial order of ten SKUs of hemp-extract based cannabidiol (CBD) products from its RapidCBD™ and Iso-Sport™ brand catalogues for more than US$1 million. The launch has commenced online and more than 45,000 units are expected to be available in up to 800 Holland & Barrett stores by the end of March, 2019 throughout the United Kingdom and the Republic of Ireland.
“Gaining a foothold in the European market and getting Isodiol products on the shelves of such a respected retailer is a significant milestone in the Company’s development,” said Isodiol’s VP of Business Development, Graham Boylan. “Although the U.K. and E.U. markets are highly regulated, the opportunities to provide Isodiol’s pioneering hemp-based consumer packaged goods (CPG) to a new and growing CBD market outweigh those challenges. Holland & Barrett has led the way in selling CBD in the U.K., and we look forward to providing additional first-to-market U.K.- and E.U.- compliant CBD product offerings in the near future, to ensure that together we remain ahead of the pack.”
This news follows the company’s late-February announcement of its partnership with the Asian American Trade Associations Council for the company’s convenience store (C-Store) retail program into an initial 1,250 locations in the United States, with expansion plans of up to 10,000 additional locations. Isodiol will launch its Fast CBD Relief™ brand from the CBD Naturals® brands portfolio as its flagship CBD products in its C-Store program.
Shineco, Inc. (TYHT) announced entering into three separate agreements with the Hemp Research Institute of the Chinese Academy of Agricultural Sciences (“HRI”) which include an industrial cannabis technology transfer agreement, an industrial cannabis apocynum planting technical service agreement and a hemp industry technical service and product R&D cooperation framework agreement.
Mr. Yuying Zhang, Chairman and CEO, commented, “We view these three agreements with the Hemp Research Institute of the Chinese Academy of Agricultural Sciences as important milestones for Shineco. We believe our new business line of industrial cannabis will benefit from the industrial cannabis strains produced by the HRI, which are suitable for industrial production, as well as the technical knowledge and other resources that HRI possesses. We are happy to innovate in the industrial cannabis market as we leverage our long-time expertise in augmenting hemp production with technology and our extensive knowledge in other agricultural products.”
This news followed yesterday’s announcement of having established a wholly owned subsidiary named Beijing Tenjove Newhemp Biotechnology Co., Ltd. on March 13, 2019 to enter the industrial cannabis market. Shineco has formulated a strategic development plan based its experience in the Apocynum, a type of hemp, industry and intends to implement a strategic development plan in the industrial cannabis market which includes planting, processing, CBD derivatives development and the comprehensive utilization of industrial hemp.
This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018 and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam owns 77,000 shares of Leafbuyer Technologies. Midam may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.